TRANSGENE Announces the Nomination of Two New Board Members

Published: Jun 27, 2013

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Regulatory News:

Transgene SA (Paris:TNG), a biopharmaceutical company that develops immunotherapy products to treat major unmet medical needs in cancer and chronic infectious diseases, today announced that two new members of the board were elected at the Annual General Meeting held on June 19, Prof. Laurence Zitvogel and Mr Jean-Luc Bélingard, in replacement respectively of Prof. Christian Bréchot (MD) and Mr Georges Hibon who did not stand for reelection.

Help employers find you! Check out all the jobs and post your resume.

Back to news